Skip to main content

Table 1 Characteristics of the breast cancer cases and controls

From: Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II

Variable

Cases (n = 648)

Controls (n = 659)

P diffa

Age at blood draw (years; mean ± SD)

69.2 (5.8)

69.3 (5.76)

P = 0.93

Age at diagnosis (years; mean ± SD)

68.9 (6.25)

-

-

BMI (kg/m2; mean ± SD)

25.2 (4.54)

25.5 (4.56)

P = 0.22

Adult weight change (lb; mean ± SD)

27.9 (25.65)

27.1 (25.91)

P = 0.58

Race (n [%])

   

   White

642 (99.1)

653 (99.1)

P = 0.98

   Other

6 (0.9)

6 (0.9)

 

BMI (kg/m2; n [%])

   

   <25

364 (56.2)

338 (51.3)

P = 0.16

   25–30

170 (26.2)

210 (31.9)

 

   30+

106 (16.4)

103 (15.6)

 

   Missing

8 (1.2)

8 (1.2)

 

History of breast cysts (n [%])

   

   No

402 (62)

460 (69.8)

P = 0.003

   Yes

246 (38)

199 (30.2)

 

Postmenopausal hormone use (n [%])

   

   Never

213 (32.9)

255 (38.7)

P < 0.0001

   ERT

204 (31.5)

260 (39.5)

 

   CHRT

203 (31.3)

120 (18.2)

 

   Unknown

28 (4.3)

24 (3.6)

 

Family history of breast cancer (n [%])

   

   No

513 (79.2)

564 (85.6)

P = 0.002

   Yes

135 (20.8)

95 (14.4)

 

Education (n [%])

   

   <High school

7 (1.1)

25 (3.8)

P = 0.0008

   High school

166 (25.6)

196 (29.7)

 

   Some college

181 (27.9)

190 (28.8)

 

   College +

294 (45.4)

248 (37.6)

 

Age at menopause (years; n [%])

   

   <40

55 (8.5)

72 (10.9)

P = 0.002

   40 to 44

65 (10)

85 (12.9)

 

   45 to 49

139 (21.5)

179 (27.2)

 

   50 to 54

301 (46.5)

258 (39.2)

 

   55+

88 (13.6)

65 (9.9)

 
  1. a P value is a t-test for the means, and a Pearson χ2 for the frequencies. BMI, body mass index; CHRT, combined hormone replacement therapy; ERT, estrogen replacement therapy; SD, standard deviation.